NAMA
MCRB icon

Nikko Asset Management Americas’s Seres Therapeutics MCRB Stock Holding History

Nikko Asset Management Americas’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-34,839
Closed -$2.34M – 217
2022
Q2 		$2.34M Sell
34,839
-1,524
-4% -$131K 0.03% 150
2022
Q1 		$5.11M Sell
36,363
-2,913
-7% -$448K 0.04% 129
2021
Q4 		$6.57M Sell
39,276
-4,470
-10% -$710K 0.03% 126
2021
Q3 		$6.09M Sell
43,746
-220,262
-83% -$43.1M 0.03% 134
2021
Q2 		$119M Sell
264,008
-35,960
-12% -$15.2M 0.47% 54
2021
Q1 		$124M Buy
299,968
+8,788
+3% +$4.05M 0.61% 46
2020
Q4 		$143M Buy
291,180
+14,596
+5% +$8.55M 0.81% 43
2020
Q3 		$152M Sell
276,584
-93,428
-25% -$31.1M 1.35% 26
2020
Q2 		$34.8M Sell
370,012
-50,904
-12% -$4.47M 0.46% 52
2020
Q1 		$30.1M Buy
420,916
+7,255
+2% +$487K 0.56% 48
2019
Q4 		$28.5M Buy
413,661
+30,563
+8% +$2.27M 0.45% 60
2019
Q3 		$30.7M Buy
383,098
+140,944
+58% +$9.31M 0.55% 51
2019
Q2 		$15.6M Buy
242,154
+201,229
+492% +$19.1M 0.31% 70
2019
Q1 		$5.62M Buy
40,925
+40,762
+25,007% +$4.97M 0.15% 105
2018
Q4 		$15K Sell
163
-3
-2% -$420 ﹤0.01% 142
2018
Q3 		$25K Buy
+166
New +$26.9K ﹤0.01% 143

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Nikko Asset Management Americas's MCRB Position: Q3 2022 in Review

Nikko Asset Management Americas sold out of Seres Therapeutics (MCRB) in Q3 2022, closing a stake of 34,839 shares — an estimated $2.34M sold.

Nikko Asset Management Americas first reported a position in MCRB in Q3 2018 and held it in 16 quarters. The position peaked at $152M in Q3 2020. 119 funds tracked by Wall St. Rank hold MCRB as of Q3 2022.

  • Nikko Asset Management Americas reported no remaining Seres Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Nikko Asset Management Americas sold 34,839 Seres Therapeutics shares in Q3 2022, an estimated $2.34M.
  • Nikko Asset Management Americas first reported a position in Seres Therapeutics in Q3 2018 and held it in 16 quarters.
  • Nikko Asset Management Americas's Seres Therapeutics position peaked at $152M in Q3 2020.
  • 119 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2022.

Based on Nikko Asset Management Americas's 13F filing for Q3 2022, filed 14 Nov 2022.